Cleveland Biolabs, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 14, 2020 at 08:33 am EDT
Cleveland BioLabs, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 592,191 compared to USD 771,602 a year ago. Net loss was USD 369,838 compared to USD 616,828 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago. For the half year, operating loss was USD 1.036 million compared to USD 1.561 million a year ago. Net loss was USD 958,370 compared to USD 1.489 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.13 a year ago.